How Sample Preparation Affects GC-MS Results: Purge-and-Trap, Headspace, Derivatization & More
INTRODUCTION GC-MS sample preparation is the critical foundation that determines the success or failure of your analytical results. While modern […]
Advanced GC-MS/MS Method Development for Volatile Nitrosamines (e.g., NDMA, NDEA)
Summary Introduction: GC-MS Method Development for Nitrosamine Testing GC-MS Method Development for Nitrosamine Testing is critical for protecting patient safety,
Advanced GC-MS/MS Method Development for Volatile Nitrosamines (e.g., NDMA, NDEA) Read More »
Overcoming Matrix Effects in LC-MS/MS for Trace-Level Nitrosamines
Introduction The accurate analysis of trace-level nitrosamines presents significant analytical difficulties, with Overcoming Matrix Effects in LC-MS/MS being one of
Overcoming Matrix Effects in LC-MS/MS for Trace-Level Nitrosamines Read More »
Understanding GC-MS Chromatograms: How to Interpret Retention Time, Fragmentation Patterns & Spectra
Introduction GC-MS chromatogram interpretation is the foundation of accurate analytical chemistry, enabling scientists to identify and quantify chemical compounds with
Nitrosamine Testing for High-Risk Drug Classes Under Continuous Manufacturing Conditions
Key Takeaways Introduction: The Convergence of High-Risk Drug Classes and Continuous Manufacturing Nitrosamine Testing for High-Risk Drug Classes under continuous
Nitrosamine Testing for High-Risk Drug Classes Under Continuous Manufacturing Conditions Read More »
How Supplier Qualification Impacts Nitrosamine Control: A Quality & Procurement Guide
Nitrosamine control during supplier qualification represents a critical intersection of regulatory compliance, quality assurance, and procurement strategy in pharmaceutical manufacturing.
How Supplier Qualification Impacts Nitrosamine Control: A Quality & Procurement Guide Read More »
GC-MS vs. GC-MS/MS: When Do You Need Tandem Mass Spectrometry for Your Samples?
Introduction: When analyzing volatile and semi-volatile compounds, choosing between GC-MS vs GC-MS/MS can significantly impact your analytical results, detection capabilities,
GC-MS vs. GC-MS/MS: When Do You Need Tandem Mass Spectrometry for Your Samples? Read More »
Peptide Characterization of Ganirelix Generic Project Submission to USFDA
Summary of Key Insights ✅ Comprehensive overview of the Peptide Characterization of Ganirelix Generic Project developed to support a successful
Peptide Characterization of Ganirelix Generic Project Submission to USFDA Read More »
Peptide Characterization of Lanreotide Generic Project Submission to USFDA
Summary Introduction: Why Peptide Characterization of Lanreotide Generic Project is Critical for USFDA Submission The Peptide Characterization of Lanreotide Generic
Peptide Characterization of Lanreotide Generic Project Submission to USFDA Read More »
PLGA Polymer Characterization for Generic Drug Development: What Innovators Don’t Disclose
Introduction: PLGA polymer characterization for generics represents one of the most challenging aspects of developing complex injectable drug products, yet